MedPath

eoadjuvant chemoradiation in locally advanced gall bladder cancer

Phase 2
Conditions
Health Condition 1: C23- Malignant neoplasm of gallbladder
Registration Number
CTRI/2021/03/031918
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Histological proven case of gall bladder cancer

2.Locally advanced gall bladder tumors staged as T3/T4, N1/N2 as per the 8th edition of TNM classification of the American Joint Committee on Cancer, with nodes along the common hepatic artery, cystic duct, hepatoduodenal ligament, periportal, peripancreatic and and periduodenal nodes, or T4 tumors that had >2 cm liver invasion.

3.Normal hematological, renal and hepatic functions (serum bilirubin <3 mg/dl).

Exclusion Criteria

1.Age < 18 years

2.History of prior radiotherapy and chemotherapy

3.H/o prior malignancy

4.Unwilling for written informed consent and follow-up

5.Patients with retroperitoneal nodes

6.Distant metastasis

7.Major medical illness or psychiatric impairment that will prevent completion of protocol or would interfere with follow-up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath